Stay updated on EN3835 for Edematous Fibrosclerotic Panniculopathy Clinical Trial
Sign up to get notified when there's something new on the EN3835 for Edematous Fibrosclerotic Panniculopathy Clinical Trial page.

Latest updates to the EN3835 for Edematous Fibrosclerotic Panniculopathy Clinical Trial page
- CheckyesterdayChange DetectedNew help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment section was updated; the recruitment note now shows No longer looking for participants, and the page revision updated to v3.6.0.SummaryDifference0.4%

- Check9 days agoChange DetectedEndo Pharmaceuticals was replaced with Endo USA Inc., a Keenova Therapeutics Company as the sponsor. The document revision was updated from v3.5.4 to v3.5.5.SummaryDifference0.3%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a minor page revision. This change does not alter the study details, eligibility criteria, or results.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3 on the page. This signals a new version of the page without substantive changes to the displayed study details.SummaryDifference0.0%

- Check59 days agoChange DetectedUpdated the page revision from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check87 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This is a backend maintenance update and does not change study content or visible functionality.SummaryDifference0.0%

Stay in the know with updates to EN3835 for Edematous Fibrosclerotic Panniculopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EN3835 for Edematous Fibrosclerotic Panniculopathy Clinical Trial page.